(Q40894077)

24 September 2017

title

IL-1beta and ICE mRNA are not altered upon beta-amyloid(25-35) induced neurotoxicity in human neuroblastoma cells (English)

1 reference

24 September 2017

1 reference

1 reference

4

1 reference

24 September 2017

3

Winblad B

1 reference

24 September 2017

Diana A

1

1 reference

24 September 2017

Eriksson C

series ordinal

2

1 reference

24 September 2017

publication date

1 April 2000

1 reference

International Journal of Developmental Neuroscience

24 September 2017

published in

1 reference

24 September 2017

volume

18

1 reference

24 September 2017

issue

2-3

1 reference

24 September 2017

page(s)

237-246

1 reference

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-6 and α-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-1 immunoreactive innervation of the human hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Molecular cloning of the interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Inflammatory mechanisms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Prevention of vertebrate neuronal death by the crmA gene

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-1 beta converting enzyme (ICE) is preferentially expressed in neuroblastomas with favourable prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Immunoreactive interleukin-1 beta localization in the rat forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Apoptosis is induced by beta-amyloid in cultured central nervous system neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Peptide inhibitors of the ice protease family arrest programmed cell death of motoneurons in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Use of monoclonal antibodies to study interleukin-1 beta-converting enzyme expression: only precursor forms are detected in interleukin-1 beta-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-1-like activity in rat brain: sources, targets, and effect of injury

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

The nucleotide sequence of the rat cytoplasmic β–actin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Effect of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Interleukin-1 receptor antagonist protein and mRNA in the rat adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Amyloid beta-protein induces necrotic cell death mediated by ICE cascade in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0736-5748%2899%2900092-1

7 January 2021

10.1016/S0736-5748(99)00092-1

Identifiers

DOI

1 reference

24 September 2017

1 reference